Guardant Health (GH) Gains from Investment Securities (2017 - 2026)

Guardant Health (GH) has 10 years of Gains from Investment Securities data on file, last reported at $20.6 million in Q1 2026.

• Quarterly Gains from Investment Securities rose 1292.26% year-over-year to $20.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.3 million (up 478.5% YoY) and the FY2025 annual result came in at $869000.0, up 114.93% from the prior year.
• Gains from Investment Securities advanced to $20.6 million in Q1 2026 per GH's latest filing, from $254000.0 in the prior quarter.
• The five-year high for Gains from Investment Securities was $24.6 million in Q2 2025, with the low at -$22.3 million in Q3 2025.
• Average Gains from Investment Securities over 5 years is $1.0 million, with a median of -$21000.0 recorded in 2022.
• Year-over-year, Gains from Investment Securities soared 51275.0% in 2022 and sank 2676.99% in 2024.
• Guardant Health's Gains from Investment Securities stood at -$4.2 million in 2022, then jumped by 154.63% to $2.3 million in 2023, then plunged by 287.89% to -$4.3 million in 2024, then surged by 105.87% to $254000.0 in 2025, then surged by 8029.92% to $20.6 million in 2026.
• Business Quant data shows GH's Gains from Investment Securities at $20.6 million in Q1 2026, $254000.0 in Q4 2025, and -$22.3 million in Q3 2025.